Study Goals

The major goals of the study on non-syndromic hearing loss (NSHL) at The Rockefeller University are: to localize novel NSHL gene(s); refine the genetic region for known NSHL loci; and isolate NSHL genes.  This study offers the basic research which will aid in understanding the function of genes controlling the mechanism of hearing.  This knowledge in turn should facilitate the development of intervention strategies to prevent and treat hearing loss. 

Background Information on Non-Syndromic Hearing Loss (updated 3/8/04)

Hearing impairment, which ranges in severity from modest difficulty with speech comprehension through profound hearing loss, affects 28 million Americans. Approximately one in every thousand children is born with a significant hearing impairment.  An additional 1/1,000 children become severely hearing impaired before adulthood (Morton 1991; Reardon 1992).  More than 60 percent of the cases of profound early-onset deafness are caused by genetic factors, which in most cases are due to single gene mutations (Marazita et al. 1993).  About 75 percent of individuals with genetically determined deafness have no other clinical features, the other 25% have identifiable syndromes (Morton 1991; Reardon 1992; Marazita et al. 1993).  It is estimated that approximately 75% of cases display autosomal recessive inheritance, 15% of cases are autosomal dominant and 2-3% cases are X-linked (Fraser 1976).  NSHL can also be due to mitochondrial inheritance (Prezant et al. 1993).

It is estimated that for NSRHL (autosomal recessive NSHL) there are between 30-100 genes (Chung et al. 1959, Morton 1991).  Over 60 NSHL loci have been localized (33 autosomal dominant loci [DFNA], 29 autosomal recessive loci [DFNB] and 5 X-linked loci [DFN]). Twenty one genes have been identified. 

Table 1: Identified Genes for Non-sydromic Hearing Loss. Table 1

Gene

OMIM

Encoded Product

Loci

Position

Reference

ACTG1

102560

 

DFNA20/26

17q25.3

Zhu et al. 2003

CDH23

605516

Cadherin-23(otocadherin)

DFNB12

10q22.1

Bork et al. 2001

CLDN14

605608

Claudin-14

DFNB29

21q22.13

Wilcox et al. 2001

COCH

601369

COCH

DFNA9

14q12

Robertson et al. 1998

COL11A2

120290

Collagen, type XI

DFNA13

6p21.32

Brown et al. 1997
McGuirt et al. 1999

CRYM

123740

CRYSTALLIN

 

16p13.11-p12.3

Abe et al., 2003

DFNA5

600994

DFNA5

DFNA5

7p15.3

Van Laer et al. 1998

DIAPH1

602121

Diaphanous 1

DFNA1

5q31.3

Lynch et al. 1997

EYA4

601316  EYA (Eye Absent - transcriptonal act.) DFNA10

6q23.2

Wayne el at. 2001
GJA1 121014 connexin 43  

6q22.31

Liu et al. 2001

GJB2 (Cx26)

121011

Connexin 26

DFNA3
DFNB1

13q12.11

Kelsell et al. 1997

GJB3 (Cx31)

603324

Connexin 31

DFNA2

1p34.3

Xia et al. 1998

GJB6 (Cx30)

604418

Connexin 30

DFNA3

13q12.11

Grifa et al. 1999

HARMONIN 605242 HARMONIN DFNB18

11p15.1

Ahmed et al, 2002

KCNQ4

603537

KCNQ4

DFNA2

1p34.2

Kubisch et al. 1999

MYH9

160775

Myosin-9

DFNA17

22q12.3

Lawani et al. 2000

MYO1A

601478

Myosin IA

DFNA48

12q13.3

Donaudy et al., 2003

MYO3A 606808 Myosin IIIA DFNB30

10q11.1

Walsh et al. 2002
MYO6 600970 Myosin-VI DFNA22
DFNB37

6q14.1

Melchionda et al. 2001
Ahmed et al, 2003

MYO7A

276903

Myosin VIIA

DFNA11
DFNB2

11q13.5

Liu et al. 1997a
Liu et al. 1997b
Weil et al. 1997

MYO15

602666

Myosin XV

DFNB3

17p11.2

Wang et al. 1998

OTOA 607038 otoancorin DFNB22

16p12.2

Zwaenepoel et al. 2002

OTOF

603681

Otoferlin

DFNB9 

2p23.3

Yasunaga et al. 1999

PCDH15

605514

Protocadherin 15

DFNB23

10q21-q22

Ahmed et al, 2003

PDS/SLC26A4

274600

Pendrin

DFNB4

7q31.1

Li et al. 1998
Cremers et al. 1998
Phelps et al. 1998

Tsukamoto et al. 2003

POU4F3

602460

POU4F3

DFNA15

5q32

Vahava et al. 1998

POU3F4

300039

POU3F4

DFN3

Xq21

Bitner et al. 1995
Hagiwara et al. 1998

Oh et al. 2003

SLC26A5

604943

Prestin

 

7q22.1

Zheng et al. 2000
Oliver et al. 2001
Liu et al, 2003

STRC

606440

Stereocilin

DFNB16

15q15

Verpy et al. 2001

TECTA

602574 

Alpha-Tectorin

DFNA8/12
DFNB21

11q23.3

Verhoeven et al. 1998
Mustapha et al. 1999

TFCP2L3

 

Unknown

DFNB28

8q22

Peters et al. 2000

TMC1 606706 TMC1 DFNA36
DFNB7/B11

9q21.13

Kurima et al. 2002
Vreugde et al. 2002
TMIE 607237 TMIE (transmembrane inner ear expressed gene) DFNB6
DFNA36

3p21

Mitchem et al. 2000
Naz et al. 2002

TMPRSS3

605511

Transmembrane protease, serine 3

DRNB8/10

21q22

Scott et al. 2001

WFS1 606201 Wolframin DFNA6/14

4p16.1

Bespalova et al. 2001
WHRN 607928 CASK DFNB31

9q32

Mburu et al. 2003
Yap et al. 2003

Table 2 and Table 3 provides genetic and clinical information for NSDHL and NSRHL, respectively.  In Tables 2  and  3 the columns are as follows: 1) locus name (hot link to OMIM entry); 2) chromosomal location; 3) the gene; 4) origin of families which have shown linkage to a particular locus; 5) age of onset; 6) evolution of hearing loss; 7) affected frequencies; and 8) most important reference(s).

Table 2: Identified Autosomal Dominant Loci for Non-sydromic Hearing Loss. Table 2
 

Locus
(OMIM #)

Location

Gene

Origin of Families

Onset

Evolution

Affected Frequencies

Most Important Reference(s) 

DFNA1
(124900)

5q31

DIAPH1

Costa Rica

5-20 yrs

Progressive starting in the low frequencies

All

Leon et al. 1992; Lynch et al. 1997

DFNA2 (600101)

1p34

GJB3
KCNQ4

Indonesia, USA, Belgium, Netherlands

Decade 1-3

Progressive to severe hearing loss

High, progressive to low

Coucke et al. 1994;
Xia et al. 1999; Kubisch et al. 1999

DFNA3 (601544)

13q12

GJB2 
GJB6

France

Prelingual

Stable or progressive, moderate to severe hearing loss 

All, greatest in high frequencies

Chaib et al. 1994; Kelsell et al. 1997; Denoyelle et al. 1998

DFNA4
(600652)

19q13

unknown

USA

Decade 3-4

Slow or rapid progression to severe hearing loss

High, progressive to low

Chen et al. 1995

DFNA5
(600994)

7p15

DFNA5

Netherlands

Decade 1-3

Progressive to severe hearing loss

High, progressive to low

Van Camp et al. 1995; 1998

DFNA6 (600965)

4p16.1

WFS1

USA (Irish descent), Netherlands

Decade 1-2

Slowly Progressive

Low, Progressive to high

Lesperance et al. 1995
Bespalova et al. 2001
Young et al. 2001

DFNA7
(601412)

1q21-q23

unknown

Norway 

Decade 1-2

Progressive

High, Progressive to low

Fagerheim et al. 1996

DFNA8/12
(601543/ 601842)

11q22-24

TECTA

Austria,
Belgium

Prelingual

Moderate to profound, non-progressive
Mild to moderately-severe hearing loss

All

Verhoeven et al. 1998

DFNA9
(601369)

14q12-q13

COCH

USA, Austria, Belgium, Nertherlands

~20 or ~40 yrs

Progressive to profound hearing loss, starting in the high frequencies

All

Manolis et al. 1996;
Robertson et al. 1998; Fransen E et al. 1999; Kamarinos M et al. 2001

DFNA10
(601316)

6q22-q23

EYA4

USA, Belgium

Decade 2-4

Postlingual, slow or rapid progression to severe hearing loss

All

Wayne et al. 2001

DFNA11
(601317)

11q12.3-q21

MYO7A

Japan

Postlingual, 1st Decade

Moderate, progressive

All

Tamagawa et al. 1996
Liu et al. 1997

DFNA13
(601868)

6p21

COL11A2

USA, Dutch

Decade 2-4

Nonprogressive, predominantly affects middle frequencies

All

Brown et al. 1997
McGuirt et al. 1999

DFNA14
(605957)

4p16.1

WFS1

Dutch, USA (Irish descent)

Decades 1-2

Stops short of profound deafness

low and mid frequencies

Van Camp et al. 1999
Bespalova et al. 2001

DFNA15 (602459)

5q31

POU4F3

Israel

18-30 yrs of age

Progreessive hearing loss, moderate to severe by age 50

All

Vahava et al. 1998

DFNA16
(603964)

2q24

unknown

Japan

 

Progressive hearing loss, Mild to Moderate

Affecting mainly the high frequencies 

Fukushima et al. 1999

DFNA17 (603622)

22q

MYH9

USA

1st decade of  life

Progressive to moderate to severe by the 3rd decade of life

 

Lalwani et al. 1999 Lalwani et al. 2000

DFNA18(606012)

3q22

unknown

Germany

1st decade of life

severe progressive

All

Bonsch et al. 2001

DFNA19

10 pericentromeric

unknown

 

 

 

 

Green et al. 1998

DFNA20/26 (604717)

17q25

ACTG1

USA

13-25 yrs 
of age

Progressive, first evident at 6-8 KHz

All

Morell et al. 2000
Yang et al. 2000
Zhu et al, 2003

DFNA22 (606346)

6q13

MYO6

Italy

childhood

progressive, postlingual

 

Melchionda et al. 2001

DFNA23
(605192)

14q21-q22

unknown

Switzerland
(Swiss German)

prelingual

Stable or progressive

Low, mid and high frequencies, moderate to profound

Salam et al. 2000

DFNA24
(606282)

4q35-qter

unknown

Switzerland
(Swiss German)

prelingual

nonprogressive

Affecting mainly the mid to high frequencies

Häfner et al. 2000

DFNA25
(605583)

12q21-24

unknown

Czech Republic

1st two decades of  life

progressive

high frequencies

Greene et al.
2001

DFNA27

4q12

unknown

 

11-29 yrs.
of age

Progreessive hearing loss, moderate to severe by age 40

 

Fridell et al. 1999

DFNA28

8q22

TFCP2L3

USA

postlingual

Progreessive hearing loss, moderate to severe by age 40.

high or mid-frequencies

Anderson et al. 1999
Peters et al, 2002

DFNA30
(606451)

15q26

unknown

Italy

end of 1st decade of life

Rapid progression to moderate to severe until the 4th decade of life

mid and high frequencies

Mangino et al. 2001

DFNA32

11p15

unknown

USA

 

Progressive   hearing loss

 

Li et al. 2000

DFNA34

1q44

unknown

 

3rd or 4th decade

Slow progressive rate

 

Kurima et al. 2000

DFNA36
(606705)

9q13-q21

TMC1

USA

1st decade

Rapidly progresses to profound by early   adulthood

 

Kurima et al. 2002

DFNA37

1p21

unknown

USA

prelingual

High progressing to low

 

Talebizadeh et al. 2000

DFNA39
(605594)

4q21.3

DSPP

 Chinese

 3rd and 5th decade

 Progressive, moderate to severe

progressive high frequency and low

Xiao et al. 2001

DFNA41

12q24-qter

unknown

Chinese

after their teens

Progressive, from moderate to profound loss

All

Liu et al. 2001

DFNA43

2q12

unknown

Italian

second decade of life

Subsequent gradual progression from moderate to profound loss

All

E. Flex et al. 2002

DFNA44
(607453)

3q28-29

unknown

Spanish

 

Bilateral and progressive

 

Modamio-Hoybjor et al. 2003

DFNA47

9p21-22

unknown

Italian

after their teens

Progressive, subsequent gradual progression to a moderate-severe loss

 

D'Adamo et al. 2003

DFNA48

12q13-q14

unknown

Italian

 

 

 

D'Adamo et al. 2003


Table 3: Identified Autosomal Recessive Loci for Non-sydromic Hearing Loss.Table 3
 

Locus
(OMIM #)

Location

Gene

Origin of Families

Onset

Evolution

Affected Frequencies

Most Important Reference(s)

DFNB1 (220290)

13q12

GJB2

Tunisia, Israel (Bedouin), Pakistan,  Australian

Usually prelingual

Stable, severe-to-profound loss

All

Guilford et al. 1994a
Kelsell et al. 1997

DFNB2 (600060)

11q13.5

MYO7A

Tunisia

Birth-16yrs

Stable, profound

All

Guilford et al. 1994b
Liu et al. 1997
Weil et al. 1997

DFNB3 (600316)

17p11.2-q12

MYO15

Bali, India

Congenital

Stable, profound

All

Friedman et al. 1995
Wang et al. 1998

DFNB4 (600791)

7q31

PDS
SLC26A4

Israel (Druze)

Congenital

Stable, severe-to-profound

All

Baldwin et al. 1995
Li et al. 1998

DFNB5
(600792)

14q12

unknown

India

Congenital

Stable, Severe-to-profound loss

All

Fukishima et al. 1995a

DFNB6 (600971)

3p14-p21

TMIE

India

Congenital

Stable, Severe-to-profound loss

All

Fukishima et al. 1995b
Naz et al. 2002

DFNB7/11 (600974)

9q13-q21

TMC1

India, Israel (Bedouin)

Congenital

Stable, Severe-to-profound loss/ Profound

All

Jain et al. 1995
Scott et al.1996

Kurima et al. 2002

DFNB8/10 (601072)

21q22

TMPRSS3

Pakistan, Israel (Palestinian)

10-12yrs/ Congenital

Progressive to severe hearing loss/ Stable, severe loss

All

Veske et al. 1996 
Scott et al. 2001

DFNB9 (601071)

2p22-p23

OTOF

Lebanon, Turkey

Congenital

Stable, profound

All

Chaib et al. 1996a
Yasunaga et al. 1999

DFNB12 (601386)

10q21-22

CDH23

Syrian

Congenital

Stable, profound

All

Chaib et al. 1996b
Bork et al. 2001 

DFNB13 (603098)

7q34-36

unknown

Lebanon

Prelingual

Severe progressive

 

Mustapha et al. 1998

DFNB14 (603678)

7q31

unknown

Lebanon

Prelingual

Profound

 

Mustapha et al. 1998

DFNB15 (601869)

3q21-q25 
19p13

unknown

India

Prelingual

Stable

All

Chen et al. 1997

DFNB16 (603720)

15q15
15q21-22

STRC

Pakistan, Palistine, Syria,
France

 3-5 years
of age

Non-progressive, moderate mid frequencies and severe high frequencies

All

Campbell et al. 1997
Verpy et al. 2001

DFNB17 (603010)

7q31

unknown

India, Middle Eastern Druze

Prelingual

Profound

All

Greinwald et al. 1998

DFNB18 (602092)

11p14-15.1

USH1C

India

 

Profound

 

Jain et al. 1998
Ahmed et al, Human Genetics online

DFNB19

18p11

unknown

 

Congenital

Profound

All

Green et al. 1998

DFNB20 (604060)

11q25-qter

unknown

Pakistan

3 months ~ 1 year of age

Profound

All

Moynihan et al. 1999

DFNB21 (603629)

11q

TECTA

Lebanon

Prelingual

Profound

Moderately severe ~ all

Mustapha et al. 1999

DFNB22 (607038)

16p12.2

OTOA

Palestine

 

Profound

 

Zwaenepoel et al. 2002

DFNB23

10p11.2-q21

PCDH15

 

 

 

 

Ahmed et al, 2003

DFNB24

11q23

unknown

 

 

 

 

Richard Smith, unpublished

DFNB25

4p15.3-q12

unknown

 

 

 

 

Richard Smith, unpublished

DFNB26 (605428)

4q31

unknown

Pakistan

Prelingual

Profound

All

Riazuddin et al. 2000

DFNB27
(605818)

2q23-q31

unknown

United Arab Emirate

      Pulleyn et al. 2000

DFNB28

22q13

unknown

Palestine

Prelingual

Profound

 

Walsh et al, 2000

DFNB29
(605608)

21q22

CLDN14